Marinomed Biotech AG (FRA:93Z)
Germany
· Delayed Price · Currency is EUR 18.35
0.00 (0.00%)
At close: Dec 5, 2025
Marinomed Biotech AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 9.12 | -15.42 | -6.37 | -6.4 | -5.89 | -6.01 | Upgrade
|
| Depreciation & Amortization | 0.36 | 0.41 | 0.45 | 0.4 | 0.38 | 0.23 | Upgrade
|
| Other Amortization | - | - | - | 0.27 | 0.23 | 0.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0.01 | - | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.65 | 0.65 | - | - | - | - | Upgrade
|
| Other Operating Activities | -10.93 | 11.95 | 2.21 | 0.99 | 1.23 | 0.23 | Upgrade
|
| Change in Accounts Receivable | - | - | - | 1.52 | -0.78 | -2.04 | Upgrade
|
| Change in Inventory | - | - | - | -0.53 | -0.1 | -0.83 | Upgrade
|
| Change in Accounts Payable | - | - | - | -1.45 | 0.85 | 1.34 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | 0.01 | -0.77 | 0 | Upgrade
|
| Operating Cash Flow | -0.8 | -2.4 | -3.7 | -5.2 | -4.87 | -6.88 | Upgrade
|
| Capital Expenditures | - | - | - | -0.23 | -0.92 | -3.96 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.02 | - | - | Upgrade
|
| Other Investing Activities | - | - | -0.1 | - | - | - | Upgrade
|
| Investing Cash Flow | - | - | -0.1 | -0.21 | -0.92 | -3.96 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 8 | 2.4 | 8 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.22 | -0.32 | -0.29 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | 7.78 | 2.08 | 7.71 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 0.3 | 0.31 | Upgrade
|
| Other Financing Activities | 1.4 | 1.6 | -1.7 | - | -0 | -0.01 | Upgrade
|
| Financing Cash Flow | 1.4 | 1.6 | -1.7 | 7.78 | 2.38 | 8.01 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0.1 | - | - | 0 | 0.03 | Upgrade
|
| Net Cash Flow | 0.6 | -0.9 | -5.5 | 2.37 | -3.4 | -2.81 | Upgrade
|
| Free Cash Flow | -0.8 | -2.4 | -3.7 | -5.43 | -5.79 | -10.85 | Upgrade
|
| Free Cash Flow Margin | -8.20% | -50.08% | -39.37% | -46.24% | -49.75% | -133.53% | Upgrade
|
| Free Cash Flow Per Share | -0.45 | -1.35 | -2.44 | -3.62 | -3.92 | -7.37 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.45 | 0.36 | 0.21 | Upgrade
|
| Levered Free Cash Flow | -1.24 | -1.1 | -3.37 | -5.17 | -5.56 | -9.54 | Upgrade
|
| Unlevered Free Cash Flow | -0.86 | -0.5 | -2.51 | -3.6 | -4.62 | -9.09 | Upgrade
|
| Change in Working Capital | - | - | - | -0.46 | -0.81 | -1.53 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.